EUVIMEDEUVIMED entdecken
EditorialLeitlinie

Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy

Carmine Zoccali iD, Francesca Mallamaci iD

Journal of Internal Medicine · 2026-08 · 300 (2) · 106-109

DOI: 10.1111/joim.70100 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Internal Medicine, online erschienen am 18.05.2026. Verfasst von Carmine Zoccali und 1 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, New York, USA. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Renal Research Institute, New York, New York, USA.
  • Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
  • Associazione Ipertensione Nefrologia Trapianto Renal (IPNET), Reggio Calabria, Italy.

ORCID-Profile: Carmine Zoccali, Francesca Mallamaci

Zitieren

APA

Zoccali, C., & Mallamaci, F. (2026). Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy. Journal of Internal Medicine, 300(2), 106-109. https://doi.org/10.1111/joim.70100

Vancouver

Zoccali C, Mallamaci F. Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy. Journal of Internal Medicine. 2026;300(2):106-109. doi:10.1111/joim.70100

BibTeX
@article{Zoccali2026,
  author = {Zoccali, Carmine and Mallamaci, Francesca},
  title = {Potassium binders as enablers of guideline‐directed renin–angiotensin–aldosterone system inhibitor therapy},
  journal = {Journal of Internal Medicine},
  year = {2026},
  volume = {300},
  number = {2},
  pages = {106--109},
  doi = {10.1111/joim.70100}
}
Kostenlos starten →